Attached files

file filename
EX-10.35 - EXHIBIT 10.35 - Spark Therapeutics, Inc.exhibit1035pfizerlicenseag.htm
EX-32.2 - EXHIBIT 32.2 - Spark Therapeutics, Inc.spark20171231ex-322.htm
EX-32.1 - EXHIBIT 32.1 - Spark Therapeutics, Inc.spark-20171231exx321.htm
EX-31.2 - EXHIBIT 31.2 - Spark Therapeutics, Inc.spark-20171231exx312.htm
EX-31.1 - EXHIBIT 31.1 - Spark Therapeutics, Inc.spark-20171231exx311.htm
EX-23.1 - EXHIBIT 23.1 - Spark Therapeutics, Inc.exhibit231-kpmg2017consent.htm
EX-10.37 - EXHIBIT 10.37 - Spark Therapeutics, Inc.exhibit1037novartislicensi.htm
EX-10.36 - EXHIBIT 10.36 - Spark Therapeutics, Inc.exhibit1036novartissupplya.htm
EX-10.34 - EXHIBIT 10.34 - Spark Therapeutics, Inc.exhibit1034brandywinelease.htm
10-K - 10-K - Spark Therapeutics, Inc.spark-201710xk.htm


Exhibit 21.1


The following is a list of subsidiaries of the Company as of December 31, 2017:
Name
 
Jurisdiction of Incorporation
Spark Therapeutics, Inc.
 
Delaware
Spark Therapeutics International Holdings, Inc.
 
Delaware
Spark Therapeutics Ireland Limited
 
Ireland
Spark Therapeutics UK Limited
 
England
Spark Therapeutics Argentina Limited
 
Argentina
Spark Therapeutics Switzerland Limited
 
Switzerland
Spark Therapeutics Germany Limited
 
Germany
Spark Therapeutics France Limited
 
France
Spark Therapeutics Brazil Limited
 
Brazil